There were no statistical differences in the percentage of patients in clinical remission at week 8 between colestyramine and hydroxypropyl cellulose with either intention-to-treat ( 53.8 % vs. 38.4 % ; P = 0.43 ) or per-protocol ( 63.6 % vs. 38.4 % ; P = 0.22 ) analyses .